Neoplasms, Fibroepithelial: Clinical Trials

1 trial for Neoplasms, Fibroepithelial, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1

Follow Neoplasms, Fibroepithelial: new trials by email Literature Review of Neoplasms, Fibroepithelial trials Research Report on Neoplasms, Fibroepithelial

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Abbreviated MRI Protocol: Initial Experience With DotaremĀ® (Gadoterate Meglumine)
Abbreviated MRI protocol: initial experience with DotaremĀ® (Gadoterate Meglumine) - Breast Neoplasms, Breast Diseases
Early Phase 1CompletedUniversity of Chicago502020-07-132023-12-05

Narrower conditions

Breast Diseases (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Fibroadenoma (1)

Broader conditions

Adenocarcinoma (1)  ·  Breast Carcinoma In Situ (1)  ·  Carcinoma (1)  ·  Carcinoma in Situ (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplasms, Ductal, Lobular, and Medullary (1)  ·  Neoplasms, Fibrous Tissue (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

gadoterate meglumine (1)

Sponsors

University of Chicago (1)

Countries

United States (1)

Top investigators

Hiroyuki Abe, MD (1)